Engineering the drug carrier biointerface to overcome biological barriers to drug delivery

被引:124
|
作者
Finbloom, Joel A. [1 ]
Sousa, Flavia [2 ,3 ]
Stevens, Molly M. [2 ,3 ]
Desai, Tejal A. [1 ]
机构
[1] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[2] Imperial Coll London, Dept Mat, Dept Bioengn, London SW7 2AZ, England
[3] Imperial Coll London, Inst Biomed Engn, London SW7 2AZ, England
基金
美国国家卫生研究院; 英国工程与自然科学研究理事会;
关键词
Drug delivery; Biointerface; Nanomaterials; Physicochemical; Barriers; Mucus; Tight junctions; Biofilm; Immune system; Cell uptake; CELL-PENETRATING PEPTIDES; POLYMERIC NANOPARTICLES; IN-VITRO; INTRACELLULAR DRUG; RESPONSIVE NANOPARTICLES; COATED NANOPARTICLES; TRANSDERMAL DELIVERY; PULMONARY DELIVERY; CONTROLLED-RELEASE; NEW-GENERATION;
D O I
10.1016/j.addr.2020.06.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Micro and nanoscale drug carriers must navigate through a plethora of dynamic biological systems prior to reaching their tissue or disease targets. The biological obstacles to drug delivery come in many forms and include tissue barriers, mucus and bacterial biofilm hydrogels, the immune system, and cellular uptake and intracellular trafficking. The biointerface of drug carriers influences how these carriers navigate and overcome biological barriers for successful drug delivery. In this review, we examine how key material design parameters lead to dynamic biointerfaces and improved drug delivery across biological barriers. We provide a brief overview of approaches used to engineer key physicochemical properties of drug carriers, such as morphology, surface chemistry, and topography, as well as the development of dynamic responsive materials for barrier navigation. We then discuss essential biological barriers and how biointerface engineering can enable drug carriers to better navigate and overcome these barriers to drug delivery. (C) 2020 Published by Elsevier B.V.
引用
收藏
页码:89 / 108
页数:20
相关论文
共 50 条
  • [41] Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery
    Elliott, Rebekah Omarkhail
    He, Mei
    PHARMACEUTICS, 2021, 13 (01) : 1 - 20
  • [42] Lipid formulation as a drug carrier for drug delivery
    Tomii, Y
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (06) : 467 - 474
  • [43] A "cluster bomb" oral drug delivery system to sequentially overcome the multiple absorption barriers
    Song, Qingling
    Wang, Huirui
    Yang, Junfei
    Gao, Hui
    Wang, Ke
    Wang, Hao
    Zhang, Yun
    Wang, Lei
    CHINESE CHEMICAL LETTERS, 2022, 33 (03) : 1577 - 1583
  • [44] A “cluster bomb” oral drug delivery system to sequentially overcome the multiple absorption barriers
    Qingling Song
    Huirui Wang
    Junfei Yang
    Hui Gao
    Ke Wang
    Hao Wang
    Yun Zhang
    Lei Wang
    Chinese Chemical Letters, 2022, 33 (03) : 1577 - 1583
  • [45] Nanocarriers: a tool to overcome biological barriers in siRNA delivery
    Kumari, Avnesh
    Kumar, Vineet
    Yadav, Sudesh Kumar
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (10) : 1327 - 1339
  • [46] Surface-fluorinated and pH-sensitive carboxymethyl chitosan nanoparticles to overcome biological barriers for improved drug delivery in vivo
    Cheng, Xu
    Zeng, Xiaoli
    Zheng, Yan
    Wang, Xin
    Tang, Rupei
    CARBOHYDRATE POLYMERS, 2019, 208 : 59 - 69
  • [47] Barriers to glaucoma drug delivery
    Ghate, Deepta
    Edelhauser, Henry F.
    JOURNAL OF GLAUCOMA, 2008, 17 (02) : 147 - 156
  • [48] The glyconanoparticle as carrier for drug delivery
    Zhang, Xueqin
    Huang, Gangliang
    Huang, Hualiang
    DRUG DELIVERY, 2018, 25 (01) : 1840 - 1845
  • [49] Carrier Deformability in Drug Delivery
    Jose Morilla, Maria
    Lilia Romero, Eder
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (09) : 1118 - 1134
  • [50] Engineering erythrocytes as a novel carrier for the targeted delivery of the anticancer drug paclitaxel
    Harisa, Gamaleldin I.
    Ibrahim, Mohamed F.
    Alanazi, Fars
    Shazly, Gamal A.
    SAUDI PHARMACEUTICAL JOURNAL, 2014, 22 (03) : 223 - 230